Mediq, international supplier of medical devices and pharmaceuticals, has finalized the acquisition of Diabetes Specialty Centre (DSC). Acquiring DSC strengthens the position of Byram Healthcare (United States' subsidiary of Mediq) number 4 position in this large but fragmented market.
DSC delivers insulin pumps, continuous glucose monitors and
the related supplies to frequent-user, insulin-dependent
diabetics. Mediq has been active in the US through Byram
Healthcare since 2008.
Mediq announced this acquisition in a press release on 23
April 2012. In 2010 the turnover of DSC was $ 26 million (€
19 million). The DSC results will be consolidated as of per
today.
To have press releases sent directly to your email address, please subscribe to the email alert service.
Mediq
Hertogswetering 159
3543 AS Utrecht
the Netherlands
T +31 30 282 19 11
F +31 30 289 66 50
Investors
Catrien van Buttingha Wichers
Corporate Communication Director
T +31 30 2821609
M +31 6 5339 3665
catrien.van.buttingha@mediq.com
Press
Ynte Hoekstra, Manager Corporate Communications
T +31 (0)30 282 1061
M +31 (0)6 2219 7204
ynte.hoekstra@mediq.com
Annegees van Linge (on maternity leave)
annegees.van.linge@mediq.com
distributed by |